Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian M Fearon

Showing results (1-10 of 59) with videos related to

Pageof 6
Sort By:
Drug Testing and Analysis|March 18, 2022
Human abuse liability assessment of e-cigarettes: Why, what and how?Ian M Fearon
Cardiovascular Research|January 18, 2006
OxLDL enhances L-type Ca2+ currents via lysophosphatidylcholine-induced mitochondrial reactive oxygen species (ROS) productionIan M Fearon
Biochemical and Biophysical Research Communications|October 27, 2004
Acute and chronic hypoxic regulation of recombinant hNa(v)1.5 alpha subunitsIan M Fearon, Stephen T Brown
Journal of Molecular and Cellular Cardiology|June 2, 2009
Oxidative stress and cardiovascular disease: novel tools give (free) radical insightIan M Fearon, Stephen P Faux
Biochemical and Biophysical Research Communications|November 26, 2003
GABA(B) receptor activation augments TASK-1 in MAH cells and mediates autoreceptor feedback during hypoxiaRosalyn P Johnson, Ian M Fearon
Cureus|August 21, 2025
Why We Need Greater, Not Less, Access to Reduced-Risk Nicotine ProductsIan M Fearon, Marina A Murphy
Drug Testing and Analysis|December 27, 2022
E-cigarette puffing topography: The importance of assessing user behaviour to inform emissions testingRhys Wadkin, Chris Allen, Ian M Fearon
Cureus|July 2, 2026
A Narrative Review of the Potential Impact of Next-Generation Tobacco and Nicotine Products on Cardiovascular HealthIan M Fearon, Matthew Stevenson, Thomas Nahde
Journal of Molecular and Cellular Cardiology|October 27, 2007
Peroxynitrite formation mediates LPC-induced augmentation of cardiac late sodium currentsMathieu Gautier, Henggui Zhang, Ian M Fearon
Cureus|August 4, 2025
Flavoured Vaping Products in Tobacco Harm Reduction: A Regulatory PerspectiveIan M Fearon, Matthew Stevenson, Thomas Nahde
Pageof 6

Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
Drug Testing and Analysis|March 18, 2022
Human abuse liability assessment of e-cigarettes: Why, what and how?Ian M Fearon
Cardiovascular Research|January 18, 2006
OxLDL enhances L-type Ca2+ currents via lysophosphatidylcholine-induced mitochondrial reactive oxygen species (ROS) productionIan M Fearon
Biochemical and Biophysical Research Communications|October 27, 2004
Acute and chronic hypoxic regulation of recombinant hNa(v)1.5 alpha subunitsIan M Fearon, Stephen T Brown
Journal of Molecular and Cellular Cardiology|June 2, 2009
Oxidative stress and cardiovascular disease: novel tools give (free) radical insightIan M Fearon, Stephen P Faux
Biochemical and Biophysical Research Communications|November 26, 2003
GABA(B) receptor activation augments TASK-1 in MAH cells and mediates autoreceptor feedback during hypoxiaRosalyn P Johnson, Ian M Fearon
Cureus|August 21, 2025
Why We Need Greater, Not Less, Access to Reduced-Risk Nicotine ProductsIan M Fearon, Marina A Murphy
Drug Testing and Analysis|December 27, 2022
E-cigarette puffing topography: The importance of assessing user behaviour to inform emissions testingRhys Wadkin, Chris Allen, Ian M Fearon
Cureus|July 2, 2026
A Narrative Review of the Potential Impact of Next-Generation Tobacco and Nicotine Products on Cardiovascular HealthIan M Fearon, Matthew Stevenson, Thomas Nahde
Journal of Molecular and Cellular Cardiology|October 27, 2007
Peroxynitrite formation mediates LPC-induced augmentation of cardiac late sodium currentsMathieu Gautier, Henggui Zhang, Ian M Fearon
Cureus|August 4, 2025
Flavoured Vaping Products in Tobacco Harm Reduction: A Regulatory PerspectiveIan M Fearon, Matthew Stevenson, Thomas Nahde
Pageof 6